Protein L: a novel reagent for the detection of Chimeric Antigen Receptor (CAR) expression by flow cytometry

by Zheng, Zhili, Chinnasamy, Nachimuthu, Morgan, Richard A
Published 2012

Pancreatic cancer: Hurdles in the engineering of CAR-based immunotherapies

by Abate-Daga, Daniel, Rosenberg, Steven A, Morgan, Richard A
Published 2014

The Shedding of CD62L (L-Selectin) Regulates the Acquisition of Lytic Activity in Human Tumor Reactive T Lymphocytes

by Yang, Shicheng, Liu, Fang, Wang, Qiong J., Rosenberg, Steven A., Morgan, Richard A.
Published 2011

Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia

by Tran, Eric, Chinnasamy, Dhanalakshmi, Yu, Zhiya, Morgan, Richard A., Lee, Chyi-Chia Richard, Restifo, Nicholas P., Rosenberg, Steven A.
Published 2013

Melanoma-associated B cells are distinct from peripheral blood-derived B cells, and may serve as a source of tumor-targeting antibodies

by Abate-Daga, Daniel, Alexander, Theresa A, Arons, Evgeny, Ho, Mitchell, Robbins, Paul F, Rosenberg, Steven A, Morgan, Richard A
Published 2013

A simple and robust clinical manufacturing process for the ex-vivo expansion of autologous T cells genetically engineered to express an anti-BCMA chimeric antigen receptor (CAR) fo...

by Ladd, Alden, Lilley, Graham, Li, Mingli, Cossette, Dan, Hopkins, Gregory W, Maier, Dawn, Paglia, Michael, Morgan, Richard A
Published 2015

Development of a T Cell Receptor Targeting an HLA-A*0201 Restricted Epitope from the Cancer-Testis Antigen SSX2 for Adoptive Immunotherapy of Cancer

by Abate-Daga, Daniel, Speiser, Daniel E., Chinnasamy, Nachimuthu, Zheng, Zhili, Xu, Hui, Feldman, Steven A., Rosenberg, Steven A., Morgan, Richard A.
Published 2014

A BCMA-specific CAR T cell produced with clinically scalable lentiviral and T cell manufacturing processes has potent anti-multiple myeloma activity

by Garrett, Tracy E, Chekmasova, Alena A, Evans, John W, Seidel, Stacie L, Horton, Holly M, Latimer, Howard J, Griecci, Johanna A, Horvath, Christopher J, Ryu, Byoung Y, Friedman, Kevin M, Morgan, Richard A
Published 2015

Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells

by Beard, Rachel E, Zheng, Zhili, Lagisetty, Kiran H, Burns, William R, Tran, Eric, Hewitt, Stephen M, Abate-Daga, Daniel, Rosati, Shannon F, Fine, Howard A, Ferrone, Soldano, Rosenberg, Steven A, Morgan, Richard A
Published 2014

Stem cells and cancer immunotherapy: Arrowhead’s 2nd annual cancer immunotherapy conference

by Bot, Adrian, Chiriva-Internati, Maurizio, Cornforth, Andrew, Czerniecki, Brian J, Ferrone, Soldano, Geles, Kenneth, Greenberg, Philip D, Hurt, Elaine, Koya, Richard C, Manjili, Masoud H, Matsui, William, Morgan, Richard A, Palena, Claudia M, Powell Jr , Daniel J, Restifo, Nicholas P, Spencer, David M, Vizcardo, Raul, Wong, Albert J, Yang, Lili, Yu, John
Published 2014

Clinical scale zinc finger nuclease (ZFN)-driven gene-editing of PD-1 in tumor infiltrating lymphocytes (TIL) for the potential treatment of metastatic melanoma

by Beane, Joal D, Lee, Gary K, Zheng, Zhili, Gandhi, Nimisha, Abate-Daga, Daniel, Bharathan, Mini, Black, Mary, Mendel, Matthew, Yu, Zhiya, Kassim, Sadik H, Chandran, Smita, Giedlin, Martin, Ando, Dale, Rebar, Ed, Reik, Andreas, Holmes, Michael, Gregory, Philip D, Restifo, Nicholas P, Rosenberg, Steven A, Morgan, Richard A, Feldman, Steven A
Published 2014